Osteoinduction by repeat plasmid injection of human bone morphogenetic protein-2

Area of Science:

• Regenerative Medicine
• Gene Therapy
• Orthopedics

Background:

• Bone morphogenetic protein-2 (BMP-2) is crucial for bone healing but lacks effective delivery systems.
• Viral gene vectors pose safety risks for clinical use.
• Plasmid-based gene transfer offers a safer alternative for BMP-2 delivery.

Purpose of the Study:

• To evaluate the efficacy of repeated plasmid-based BMP-2 gene transfer for osteoinduction in skeletal muscle.
• To determine if divided, repeated dosing enhances bone formation compared to single injections.

Main Methods:

• A plasmid encoding human BMP-2 (pCAGGS-BMP-2) was injected multiple times (1-8) into mouse skeletal muscle at divided doses.
• Osteoinduction was assessed using radiography, histology, and biochemical assays.
• BMP-2 expression was confirmed via immunohistochemistry.

Main Results:

• Successful gene transfer of BMP-2 into mouse skeletal muscle was achieved through repeat injections.
• Mature bone formation was frequently observed in mice receiving repeated pCAGGS-BMP-2 injections.
• Divided, repeat dosing of the BMP-2 gene significantly enhanced osteoinduction frequency.

Conclusions:

• Repeat DNA injections of BMP-2 present a viable strategy for osteoinduction in skeletal muscle.
• This approach facilitates the clinical application of BMP-2 gene therapy for skeletal disorders.
• Direct DNA injection offers an effective and safe method for BMP-2 gene therapy.